Jing Marantz reports a stock award at Intellia Therapeutics

By AlphaYouPublished Oct 28, 2026Form 4

Stocks in this disclosure

Reported activity

Marantz Jing L.

Reporting filer

Jing Marantz reports a stock award, not an open-market purchase or sale, in Intellia Therapeutics, Inc.. Form 4 filed Oct 28, 2026 lists 2 entries.

Reported details

2 entries

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Marantz Jing L.	2026-10-26	A	Grant or award	199822	0.00	199,822	2 days	Filed terms security Title: Common Stock id: F1 transaction Date: 2026-10-26 transaction Form Type: 4 transaction Code: A equity Swap Involved: false transaction Shares: 199822 transaction Price Per Share: 0.00 transaction Acquired Disposed Code: A shares Owned Following Transaction: 199822 direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)	Marantz Jing L.	2026-10-26	A	Grant or award	275061	0	275,061	2 days	Filed terms security Title: Stock Option (right to buy) conversion Or Exercise Price: 11.26 transaction Date: 2026-10-26 transaction Form Type: 4 transaction Code: A equity Swap Involved: false transaction Shares: 275061 transaction Price Per Share: 0 transaction Acquired Disposed Code: A id: F2 expiration Date: 2036-10-25 underlying Security Title: Common Stock underlying Security Shares: 275061 shares Owned Following Transaction: 275061 direct Or Indirect Ownership: D

Owner: Marantz Jing L.
Date: 2026-10-26
Code: A
Action: Grant or award
Quantity: 199822
Price: 0.00
Following holdings: 199,822
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Common Stock
id: F1
transaction Date: 2026-10-26
transaction Form Type: 4
transaction Code: A
equity Swap Involved: false
transaction Shares: 199822
transaction Price Per Share: 0.00
transaction Acquired Disposed Code: A
shares Owned Following Transaction: 199822
direct Or Indirect Ownership: D

Owner: Marantz Jing L.
Date: 2026-10-26
Code: A
Action: Grant or award
Quantity: 275061
Price: 0
Following holdings: 275,061
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Option (right to buy)
conversion Or Exercise Price: 11.26
transaction Date: 2026-10-26
transaction Form Type: 4
transaction Code: A
equity Swap Involved: false
transaction Shares: 275061
transaction Price Per Share: 0
transaction Acquired Disposed Code: A
id: F2
expiration Date: 2036-10-25
underlying Security Title: Common Stock
underlying Security Shares: 275061
shares Owned Following Transaction: 275061
direct Or Indirect Ownership: D

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Marantz Jing L.: EVP, Chief Medical Officer.
F1: Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
F2: This option was granted on October 26, 2026 with respect to shares of Common Stock, with 33% vesting on October 26, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.

Prepared automatically from public filing data. Report a correction.